Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.

about

Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q38964908

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting Neovasculature with ...... in Non-small Cell Lung Cancer.

@en

type

Item

label

Targeting Neovasculature with ...... in Non-small Cell Lung Cancer.

@en

prefLabel

Targeting Neovasculature with ...... in Non-small Cell Lung Cancer.

@en

P1476

Targeting Neovasculature with ...... in Non-small Cell Lung Cancer

@en

P2093

Charis Maragkos

http://www.w3.org/2001/XMLSchema#string

Dimitra Grapsa

http://www.w3.org/2001/XMLSchema#string

Konstantinos N Syrigos

http://www.w3.org/2001/XMLSchema#string

P2860

Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

Cancer statistics, 2008

The biology of VEGF and its receptors

Angiogenesis in cancer and other diseases

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

Hydroxylation of HIF-1: oxygen sensing at the molecular level

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

P2888

s40259-016-0194-1

P304

421-439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40259-016-0194-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

V Skouras

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27670779

http://www.w3.org/2001/XMLSchema#string